VOYAGER THERAPEUTICS INC's ticker is VYGR and the CUSIP is 92915B106. A total of 84 filers reported holding VOYAGER THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 1.44 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $31,440 | -3.5% | 4,057 | +42.6% | 0.00% | – |
| Q2 2023 | $32,585 | +19.1% | 2,846 | -19.8% | 0.00% | – |
| Q1 2023 | $27,370 | +44.1% | 3,550 | +14.5% | 0.00% | – |
| Q4 2022 | $19,000 | +26.7% | 3,100 | +24.0% | 0.00% | – |
| Q3 2022 | $15,000 | 0.0% | 2,500 | 0.0% | 0.00% | – |
| Q2 2022 | $15,000 | -31.8% | 2,500 | -16.7% | 0.00% | – |
| Q1 2022 | $22,000 | +450.0% | 3,000 | +100.0% | 0.00% | – |
| Q4 2021 | $4,000 | +100.0% | 1,500 | +1160.5% | 0.00% | – |
| Q2 2020 | $2,000 | +100.0% | 119 | 0.0% | 0.00% | – |
| Q1 2020 | $1,000 | – | 119 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| TRV GP III, LLC | 6,391,176 | $60,077,000 | 50.34% |
| ARMISTICE CAPITAL, LLC | 2,836,000 | $26,658,000 | 2.02% |
| Casdin Capital, LLC | 1,128,075 | $10,604,000 | 1.81% |
| BB BIOTECH AG | 2,865,841 | $26,939,000 | 0.86% |
| HIGHLINE CAPITAL MANAGEMENT, L.P. | 1,284,697 | $12,076,000 | 0.81% |
| Aevitas Wealth Management, Inc. | 48,300 | $454,000 | 0.46% |
| GREAT POINT PARTNERS LLC | 365,132 | $3,432,000 | 0.43% |
| Patriot Financial Group Insurance Agency, LLC | 61,320 | $576,000 | 0.38% |
| HARBOURVEST PARTNERS LLC | 72,726 | $684,000 | 0.32% |
| Birchview Capital, LP | 33,000 | $310,000 | 0.29% |